About Us

About Us

Meaningful, innovative and evidence-based analysis to
help inform key decision making.

Our goal is to be the business intelligence partner of choice for companies in the healthcare arena looking for meaningful, innovative and evidence-based analysis to inform their key decision making. As a trusted and reliable partner, GBI Research helps clients to better understand their business environment, compete successfully within it, and to achieve growth.

At GBI Research, we leverage extensive proprietary databases and employ novel data interrogation methodologies to generate new and meaningful analyses and insights.

Our content and coverage are informed by close collaboration with a global network of domain-specific external partners; this allows us to deliver novel, thought-provoking and idea-generating insights that clients would normally struggle to access.

Our in-house team of researchers and analysts – typically with MBAs, PhDs and MScs, as well as considerable healthcare industry experience is located across the UK, US and Asia Pacific. The team provides expert and insightful commentary to support evidence-based analyses of established and emerging markets.

More than 2,000 clients benefit from the GBI Research product set. Reports are available to purchase as individual research reports or via our online subscription platform, request a demo today to see how it works.

Analyst Views

30 Jun 15
Overlap in Pathology between Cancer Sites Ushers in Wave of....
The oncology therapy area comprises a large and diverse range of indications, encompassin.....
Read post
30 Jun 15
Growing Therapeutic Options and Success of Revlimid to Char....
Multiple Myeloma (MM) is a hematological malignancy characterized by the proliferation of.....
Read post

White Papers

07 May 15
A Review of Asthma Therapeutics....
The following White Paper examines the global burden of asthma as well as current trends ....
Read post
18 Jun 14
Investigating the Clinical Trial Landscape....
The need for intelligence related to the clinical trial landscape has never been greater ....
Read post

Press Releases

30 Jun 15
Global Biosimilars Market Value Could Hit $55 Billion by 20....
The global biosimilars market value is expected to reach $20 billion by the end of 2015 a.....
Read post
17 Jun 15
Pancreatic Cancer Treatment Pipeline Dominated by Early-Sta....
While the treatment pipeline for pancreatic cancer shows a high level of innovation, with.....
Read post